Related Experiment Video
Updated: Aug 14, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents
A Begleiter1, M K Leith, G McClarty
1Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.
Abstract:
The exact contribution of the quinone group to the activity of quinone antitumor agents remains uncertain. Two L5178Y murine lymphoblastic cell lines resistant to the model quinone antitumor agent, hydrolyzed benzoquinone mustard, and one partial-revertant cell line were isolated and characterized. The antitumor activity of hydrolyzed benzoquinone mustard has been shown previously to be due to its ability to induce free radical mediated DNA strand breaks. Resistant cells were obtained by growing a cloned L5178Y parental cell line in media containing increasing concentrations of hydrolyzed benzoquinone mustard. L5178Y/HBM2 cells were selected from L5178Y cells growing in media containing 0.2 mM drug, while L5178Y/HBM10 cells were selected from cells growing in media containing 1.0 mM drug. The L5178Y/HBMR cells were obtained by growing L5178Y/HBM10 cells in media without hydrolyzed benzoquinone mustard. The resistant cell lines, L5178Y/HBM2 and L5178Y/HBM10, were 2.5- and 6-fold less sensitive, respectively, to hydrolyzed benzoquinone mustard compared to parental cells, and this was accompanied by a decrease in the formation of DNA single and double strand breaks by this drug. The partial-revertant cell line, L5178Y/HBMR was 2.9-fold less sensitive to hydrolyzed benzoquinone mustard compared to parental cells. Drug uptake appeared to be lower in the resistant cells compared to parental cells. The resistant cells had a slightly elevated level of superoxide dismutase activity compared to parental cells, but there was no increase in the mRNA for superoxide dismutase nor any amplification of the gene for this enzyme. Intracellular catalase activities of the L5178Y/HBM2 and L5178Y/HBM10 cells were elevated by 1.25- and 2.6-fold, respectively, and the increased enzyme activity in the L5178Y/HBM10 cells appeared to result from a 3.6-fold increase in mRNA for this enzyme. Glutathione peroxidase activity was slightly elevated in L5178Y/HBM2 cells, but was unchanged in the other resistant cells. The L5178Y/HBM2 and L5178Y/HBM10 cells showed increased concentrations of glutathione and elevated levels of glutathione transferase activity. The resistant cell lines also had DT-diaphorase activity that was 3- and 24-fold higher in L5178Y/HBM2 and L5178Y/HBM10 cells, respectively, compared to sensitive cells. However, cytochrome P-450 reductase activity and the ratio of reduced to oxidized pyridine nucleotides was unchanged in the resistant cell lines. The partial-revertant cell line, L5178Y/HBMR, showed approximately the same level of resistance to hydrolyzed benzoquinone mustard as the L5178Y/HBM2 cells.(ABSTRACT TRUNCATED AT 400 WORDS)
Insights
This study investigated resistance to hydrolyzed benzoquinone mustard, a quinone antitumor agent. Resistant cells showed decreased DNA breaks and altered enzyme activity, suggesting complex resistance mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Quinone antitumor agents are vital in cancer therapy, but their precise mechanism of action and resistance pathways are not fully understood.
- Hydrolyzed benzoquinone mustard's activity is linked to free radical-mediated DNA strand breaks.
- Understanding quinone drug resistance is crucial for developing more effective cancer treatments.
Purpose of the Study:
- To investigate the mechanisms of cellular resistance to hydrolyzed benzoquinone mustard, a model quinone antitumor agent.
- To characterize enzyme activity changes in resistant cell lines.
- To elucidate the role of the quinone group in antitumor activity.
Main Methods:
- Isolation and characterization of L5178Y murine lymphoblastic cell lines resistant to hydrolyzed benzoquinone mustard.
- Assessment of drug sensitivity, DNA strand break formation, and drug uptake in parental and resistant cell lines.
- Quantification of various enzyme activities, including superoxide dismutase, catalase, glutathione peroxidase, glutathione transferase, and DT-diaphorase.
Main Results:
- Resistant cell lines (L5178Y/HBM2, L5178Y/HBM10) exhibited reduced sensitivity to hydrolyzed benzoquinone mustard (2.5- to 6-fold).
- A decrease in DNA single and double strand breaks was observed in resistant cells.
- Elevated intracellular catalase, glutathione, glutathione transferase, and DT-diaphorase activities were noted in resistant cell lines, alongside reduced drug uptake.
Conclusions:
- Cellular resistance to hydrolyzed benzoquinone mustard involves decreased DNA damage and alterations in antioxidant enzyme systems.
- Increased DT-diaphorase and catalase activities appear to be key components of the resistance phenotype.
- These findings contribute to understanding quinone antitumor agent resistance and may inform future drug development.

